http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018194798-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-005 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af411f7dfc1a40eabc5f311a0e2d1a7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fdafc5d31b292a3ea48e86bea5a46a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b59506ea900cd95f01b77961eee2d3a8 |
publicationDate | 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2018194798-A1 |
titleOfInvention | Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof |
abstract | The present invention relates to the development of the cationic progesterone compounds as a novel anti-tumor agent. The present invention provides a method for the preparation of novel series of progesterone derivatives. The invention also provides information related to highly selective anti-cancer activities of these compounds in wide range of cancer cell irrespective of their progesterone receptor status. Thus, the presently disclosed cationic progesterone compounds offer a viable option as anti-cancer therapeutics. |
priorityDate | 2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 496.